Publication: Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand
Issued Date
2020-01-01
Resource Type
ISSN
14770962
09612033
09612033
Other identifier(s)
2-s2.0-85082851505
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Lupus. (2020)
Suggested Citation
Siriporn Juthong, Alan F. Geater, Paron Dekumyoy, Thanaporn Hortiwakul, Boonjing Siripaitoon, Duangkamol Aiewruengsurat, Nannapas Thongbun Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand. Lupus. (2020). doi:10.1177/0961203320911091 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54645
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand
Other Contributor(s)
Abstract
© The Author(s) 2020. Background: Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Thailand. Methods: A cross-sectional study was conducted on 180 SLE patients attending the Rheumatology Clinic at Songklanagarind Hospital. Stool specimens were collected and examined using the direct smear technique and agar plate culture technique. Serum anti-Strongyloides stercoralis IgG was measured by IgG-ELISA. Results: The overall prevalence of strongyloidiasis by combined parasitologyl and/or serology was 15.6%. The prevalence of strongyloidiasis by parasitological methods was 2.2%. Positive parasitology and/or serology was associated with male sex and a SLE disease duration of less than two years. Conclusion: Strongyloidiasis is highly prevalent among the SLE population. A combination of serological and parasitological methods increases the rate of diagnosis of strongyloidiasis in SLE patients.